<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03583398</url>
  </required_header>
  <id_info>
    <org_study_id>MUGdansk</org_study_id>
    <nct_id>NCT03583398</nct_id>
  </id_info>
  <brief_title>Health-related QoL Following TAVI TAo, TAVI TF and AVR</brief_title>
  <official_title>Health-related Quality of Life Following Transcatheter Aortic Valve Implantation Using Transaortic, Transfemoral Approaches and Surgical Aortic Valve Replacement - a Single-center Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Gdansk</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut für Pharmakologie und Präventive Medizin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Gdansk</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study was to evaluate short- and long-term changes in QoL in patients
      undergoing TAVI and to assess differences in patient QoL when using the TAVI TAo approach
      compared with the transfemoral approach (TAVI TF) and surgical aortic valve replacement
      (SAVR).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Actual">March 2018</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Health-related quality of life: EQ-5D-3L questionnaire</measure>
    <time_frame>1 month and 1 year follow-up</time_frame>
    <description>EQ-5D-3L questionnaire</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">97</enrollment>
  <condition>Quality of Life</condition>
  <arm_group>
    <arm_group_label>TAVI TAo</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>TAVI TF</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>AVR</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>transcatheter aortic valve implantation, surgical aortic valve replacement</intervention_name>
    <description>Transcatheter aortic valve implantation using transaortic and transfemoral access and surgical aortic valve replacement.</description>
    <arm_group_label>AVR</arm_group_label>
    <arm_group_label>TAVI TAo</arm_group_label>
    <arm_group_label>TAVI TF</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Elderly population with aortic valve stenosis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aortic valve stenosis

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>June 28, 2018</study_first_submitted>
  <study_first_submitted_qc>July 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2018</study_first_posted>
  <last_update_submitted>July 11, 2018</last_update_submitted>
  <last_update_submitted_qc>July 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Gdansk</investigator_affiliation>
    <investigator_full_name>Aleksandra Stańska</investigator_full_name>
    <investigator_title>MSc, Psychologist</investigator_title>
  </responsible_party>
  <keyword>TAVI</keyword>
  <keyword>quality of life</keyword>
  <keyword>SAVR</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

